SLAM
ROIV icon

Swiss Life Asset Management’s Roivant Sciences ROIV Stock Holding History

Swiss Life Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Buy
+29,280
New +$865K ﹤0.01% 691
2026
Q1 		– Sell
-17,296
Closed -$375K – 1598
2025
Q4 		$375K Buy
17,296
+2,921
+20% +$57.6K ﹤0.01% 911
2025
Q3 		$217K Buy
+14,375
New +$178K ﹤0.01% 1077

Other funds holding ROIV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $646M AUM 291.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Swiss Life Asset Management's ROIV Position: Q2 2026 in Review

Swiss Life Asset Management opened a new position in Roivant Sciences (ROIV) in Q2 2026: 29,280 shares worth $1.04M. The stake represents ﹤0.01% of the portfolio and ranks #691 among its holdings. This is a return to the name: Swiss Life Asset Management previously reported a position in ROIV as recently as Q4 2025.

Swiss Life Asset Management first reported a position in ROIV in Q3 2025 and has held it in 3 quarters since. 301 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Swiss Life Asset Management held 29,280 shares of Roivant Sciences worth $1.04M as of Q2 2026.
  • Roivant Sciences was a new Swiss Life Asset Management position in Q2 2026.
  • Roivant Sciences made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #691 holding.
  • Swiss Life Asset Management first reported a position in Roivant Sciences in Q3 2025 and has held it in 3 quarters since.
  • 301 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.